TenderlineUK
Procurement Intelligence
Official OCDSSearch

Tenderline / Tenders / NHS Midlands & East Framework for Denosumab 60mg…

Find a TenderOpen admission Tender notice
Published 18 Sept 2026, 13:48 BST

Official UK procurement notice

NHS Midlands & East Framework for Denosumab 60mg PFS

Apply via Atamis legacy domain (health-family.force.com) Official notice Competition analysis

Authority: NHS England (Central government)

Framework agreementGoodsOpen procedureAbove thresholdSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: East Midlands (UKF)West Midlands (UKG)East of England (UKH)
Framework ceiling (notional) £600,000framework ceiling, not attributable revenue
Admission open until 13 Oct 202613:00 BST · period end, not a bid countdown
Clarification cut-off 6 Oct 202613:00 BST · questions to the authority
Framework period 8 moup to 2 yrs with extensions · starts 1 Jan 2027
Bids per lot · this authority 8CPV 3360 · n=96 · competition analysis ↓

What is being bought

Published requirement description

Project title: NHS Midlands & East Framework for Denosumab 60mg PFS

Offer reference number: CM/TNS/26/5768

Period of framework: 01 January 2027 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 16 months.

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

CPV: Pharmaceutical products

How this framework works

From the published notice
Type
Open framework
Call-offs
every call-off is a further competition among the appointed suppliers
Framework period
8 mo · up to 2 yrs from 1 Jan 2027
Who may buy through it

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

Published description of the framework

Please refer to the ITO Documents for the Operation Description

The lotProcurement structure

single lot · value published
Lot #1Lot 1Renewal 8 moSMEPublished value£600,000
Contract period: 1 Jan 2027 — 31 Aug 2027 (8 mo) · up to 2 yrs with extensionsEligibility: SME eligibleDelivery: East Midlands, West Midlands, East of England
Value
£600,000 exc. VAT · £720,000 inc. VAT
Extensions
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 16 months.
33600000 Pharmaceutical products

Who is likely to bid for this lot ↓

What it takes to win

Evaluation split and conditions of participation as published — the tender pack may add more
How bids are scored
Price: 200
Published sub-criteria (2)
  • Price is not the only award criterion — 100
  • Price is not the only award criterion — 100

Competition analysis · published record, not a forecast of who will bid

How NHS England buys Pharmaceutical products (CPV 3360) — and who usually turns up

NHS England’s own published record, next to the East Midlands market for the same work. This notice is a framework or DPS, so only frameworks and DPS are compared. Whole-market view: sector page →

1

How the contest usually goes

Left: this authority. Right: the market where the work is delivered. Bids and award-vs-estimate pairs are per lot, from contested frameworks and DPS only — direct awards report one bid by definition and are left out. Empty means nothing was published, not filled in from elsewhere.

This authority

NHS England

framework/DPS notices in 36 months: 82 in CPV 3360 · 87 in division 33 (1 direct) · 130 in all categories (8 direct)

Bids per lot8CPV 3360 · 36m · n=96 lots
Single-bid lots15%CPV 3360 · 36m · n=96 lots
Award vs estimate1% belowall categories · 24m · n=82 pairs
Deadline → award27dCPV 3360 · 36m · n=23 notices
Notice updates0all categories · 24m · n=1,566 notices
Awarded without competition0%CPV 3360 · 36m · n=82 notices
Bids per lot robust · n=96
  • 1 bid 15%
  • 2–3 21%
  • 4–6 11%
  • 7+ 53%

Median 8 · 96 lots on 46 contested notices · CPV 3360.

How procedures are run robust · n=67
  • Open 100%
  • Selective 0%
  • Limited 0%
  • Direct 0%

82 notices · CPV 3360. Open and selective are contested (feed the bid/price figures above); limited and direct are not.

The market · delivery region

East Midlands · Pharmaceutical products (CPV 3360)

framework/DPS notices delivered in East Midlands in 36 months: 43 in CPV 3360 (43 contested) · 76 in division 33 (75 contested)

Bids per lot14CPV 3360 · 36m · n=33 lots
Single-bid lots0%CPV 3360 · 36m · n=33 lots
Award vs estimate—not measured on frameworks — a panel award is a ceiling, not a price
Deadline → award27dCPV 3360 · 36m · n=22 notices
SME bidders23%division 33 · 36m · n=5 lots
Winners based in the region67%division 33 · 36m · n=966 awards
Bids per lot robust · n=33
  • 1 bid 0%
  • 2–3 21%
  • 4–6 15%
  • 7+ 64%

Median 14 · 33 lots on 21 contested notices · CPV 3360.

How procedures are run robust · n=40
  • Open 100%
  • Selective 0%
  • Limited 0%
  • Direct 0%

43 notices · CPV 3360. Open and selective are contested (feed the bid/price figures above); limited and direct are not.

robust · n=82 Awards in NHS England (all categories, n=82 pairs) land a median 1% below: on this notice’s £600,000 that is about £592,800. Context for a bid, not a recommended price.

Method and what to read with care
  • Two columns, no blending. The authority column walks its own record only: notices in the 4-digit class, then the 2-digit division, then all categories (36 months, per lot, contested only), and as a last resort its 24-month row across all categories (per notice, every route). The market column is the notice’s primary delivery ITL1 × the same class, then division (36 months). Nothing is filled from the UK-wide class; an empty tile means the source published nothing usable.
  • Per lot, contested only. Find a Tender publishes bid counts per lot; a seven-lot tender is seven contests. Procedures awarded without competition (limited / direct) are excluded from bids, price pairs and decision days — they report one bid by definition. Frameworks and DPS are a separate population from contracts (6–7 bids per lot against 2–4) and only the notice’s own kind is shown.
  • Coverage. Roughly 40 % of notices publish a bid count; about half publish an ITL1 delivery location, so the market column reads the authority’s registered region when the notice has none (labelled). Award-vs-estimate pairs need a lot estimate, one active award on the lot, one canonical supplier and a gap under 60 %; about 30 % of pairs are exact matches (the buyer published the award at the estimate). n is on every figure; below 3 the tile is muted, never hidden.
  • Pounds. The expected award applies the authority’s median movement (or the region’s, when the authority has fewer than 3 pairs) to this notice’s estimate; the middle half uses the region’s quartiles. A multi-lot notice publishes an envelope, so the movement is applied per lot, never to the total. A benchmark, not a recommended price.
  • “Match” and “relevance” are model scores from the nightly matcher, not published facts. Find a Tender does not publish who is bidding. Never shown: contact details, payment behaviour, or a recommended price.

Procedure terms & legal framework

From the official record
Procedure method
Open procedure
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Goods
Notice status
Open admission
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Framework agreement
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
18 Sept 2026, 13:48 BST
Last source update
18 Sept 2026, 13:48 BST
Award evaluation window
Submission end — 27 Oct 2026, 23:59 GMT
Authority reference
CM/TNS/26/5768
Latest notice
Tender notice (UK4)
Classification (CPV)
Pharmaceutical products
Delivery area
East Midlands (UKF)West Midlands (UKG)East of England (UKH)
Official registry OCID
ocds-h6vhtk-07757b Find a Tender

How to participate & submission route

Official notice Apply via Atamis legacy domain (health-family.force.com)
Authorised e-sourcing portalAtamis legacy domain (health-family.force.com) ↗Supplier login requiredElectronic submission allowedLanguage: EN
Open official portal workspace ↗
Access & registration note: Legacy Salesforce domain still used in notices — use the current Atamis portal · this portal address is a legacy domain; the operator has migrated
Expression of interest (EOI)
—
Appointment period ends
13 Oct 2026, 13:00 BST
Clarification deadline
6 Oct 2026, 13:00 BST
Submission channel
Official e-sourcing portal
Electronic submission
Allowed
Accepted languages
en
Detailed submission instructions & authority contactsFrom official release
The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗ Additional info obtained from the abovementioned address Tenders must be submitted to the abovementioned address

Timeline

5 published dates · Europe/London
  1. Tender notice publishedearlier today
    18 Sept 2026, 13:48 BST
  2. Clarification questions byin 18 days
    6 Oct 2026, 13:00 BST
  3. Admission / appointment period endsin 25 days · period end, not a bid countdown
    13 Oct 2026, 13:00 BST
  4. Award decision expected byin 39 days
    27 Oct 2026, 23:59 GMT
  5. Contract startsin 104 days
    1 Jan 2027, 00:00 GMT

Commercial outcome & contract awards

Nothing awarded yet
Awards (0)
No award published
Contracts (0)
No contract published
Bid statistics
No aggregate bid statistics published

Notice history

1 event · 1 release on Find a Tender
  1. Tender notice published
    18 Sept 2026, 13:48 BSTUK4

Contracting authority & participating public bodies

NHS England

Contracting authorityPublic authority - central government GB-PPON: PDPT-3135-BWWY Wellington House, 133-135 Waterloo Rd, London, London, SE1 8UG
View buyer profile →

Official documents & specifications (14)

Official links; attachments are not copied

Tender pack and attachments

Show 5 more documents

Notices published for this procedure

  • Tender notice tenderTender noticeUK4Tender notice on Find a Tender